We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+19.94%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$9.37B
AUM Growth
+$1.16B
Cap. Flow
+$125M
Cap. Flow %
1.34%
Top 10 Hldgs %
19.5%
Holding
1,860
New
177
Increased
769
Reduced
722
Closed
101

Top Sells

Rank Stock Value
1
VET icon
Vermilion Energy
VET
+$20.6M
2
PL icon
Planet Labs
PL
+$17M
3
MRVL icon
Marvell Technology
MRVL
+$12.3M
4
ASTS icon
AST SpaceMobile
ASTS
+$10.5M
5
MSFT icon
Microsoft
MSFT
+$10.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.92%
2 Technology 22.36%
3 Industrials 9.58%
4 Financials 8.95%
5 Healthcare 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IETC icon
1626
iShares US Tech Independence Focused ETF
IETC
$699M
$216K ﹤0.01%
+2,010
New +$210K
SPMC
1627
Sound Point Meridian Capital
SPMC
$202M
$215K ﹤0.01%
21,700
+8,000
+58% +$83.9K
TECK icon
1628
Teck Resources
TECK
$33.9B
$215K ﹤0.01%
+3,613
New +$220K
DFEB icon
1629
FT Vest US Equity Deep Buffer ETF February
DFEB
$446M
$215K ﹤0.01%
4,253
-82
-2% -$4.08K
PS
1630
Pershing Square
PS
$15.6B
$214K ﹤0.01%
+6,500
New +$237K
CGMS icon
1631
Capital Group US Multi-Sector Income ETF
CGMS
$5.43B
$213K ﹤0.01%
7,797
-639
-8% -$17.6K
PMO
1632
Franklin Municipal Opportunities Trust
PMO
$277M
$213K ﹤0.01%
20,200
+27
+0.1% +$282
STEP icon
1633
StepStone Group
STEP
$4.19B
$213K ﹤0.01%
5,142
+726
+16% +$35.9K
SNX icon
1634
TD Synnex
SNX
$21B
$213K ﹤0.01%
+795
New +$192K
DXYZ
1635
Destiny Tech100
DXYZ
$996M
$212K ﹤0.01%
+8,248
New +$310K
AUPH icon
1636
Aurinia Pharmaceuticals
AUPH
$2.14B
$212K ﹤0.01%
12,520
-900
-7% -$14.4K
AQST icon
1637
Aquestive Therapeutics
AQST
$670M
$212K ﹤0.01%
51,052
+13,167
+35% +$55.4K
AKRE
1638
Akre Focus ETF
AKRE
$5.3B
$212K ﹤0.01%
3,991
-275
-6% -$14.9K
FLG
1639
Flagstar Bank National Association
FLG
$5.61B
$212K ﹤0.01%
14,185
NTAP icon
1640
NetApp
NTAP
$36.5B
$212K ﹤0.01%
+1,368
New +$179K
PTF icon
1641
Invesco Dorsey Wright Technology Momentum ETF
PTF
$563M
$211K ﹤0.01%
+1,551
New +$183K
DFTX
1642
Definium Therapeutics
DFTX
$5.12B
$211K ﹤0.01%
+4,490
New +$111K
MDLN
1643
Medline Inc
MDLN
$32.1B
$211K ﹤0.01%
+5,348
New +$216K
ETY icon
1644
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.3B
$209K ﹤0.01%
14,393
+94
+0.7% +$1.37K
PLXS icon
1645
Plexus
PLXS
$6.56B
$209K ﹤0.01%
+695
New +$181K
SCHA icon
1646
Schwab U.S Small- Cap ETF
SCHA
$22.9B
$209K ﹤0.01%
+5,780
New +$191K
SMTC icon
1647
Semtech
SMTC
$13.8B
$209K ﹤0.01%
1,290
-4,503
-78% -$589K
AMZA icon
1648
InfraCap MLP ETF
AMZA
$489M
$208K ﹤0.01%
4,500
RGEN icon
1649
Repligen
RGEN
$9.46B
$208K ﹤0.01%
+1,523
New +$187K
KORP icon
1650
American Century Diversified Corporate Bond ETF
KORP
$929M
$208K ﹤0.01%
4,435
+90
+2% +$4.21K

Similar funds

Oppenheimer & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Oppenheimer & Co held 1,860 positions worth $9.37B, up 14% from $8.21B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q2 2026 filing shows 177 new, 769 increased, 722 reduced and 101 closed positions. Its largest new stake was Vanguard US Momentum Factor ETF: 40,457 shares worth $10.1M. The largest sale was Vermilion Energy, an estimated $20.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Oppenheimer & Co's largest Q2 2026 buy was Vanguard US Momentum Factor ETF: 40,457 shares worth $10.1M.
  • Oppenheimer & Co added most to Eaton Vance Total Return Bond ETF in Q2 2026, an estimated $8.85M increase.
  • Oppenheimer & Co's biggest Q2 2026 reduction was Vermilion Energy, cutting an estimated $20.6M.
  • Oppenheimer & Co fully exited Invesco CurrencyShares Swiss Franc Trust in Q2 2026, selling an estimated $3.47M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $9.37B portfolio in Q2 2026.
  • Oppenheimer & Co opened 177 new positions and closed 101 in Q2 2026.
  • Oppenheimer & Co's portfolio value rose 14% quarter-over-quarter to $9.37B.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.